Venmax Drugs & Pharmaceuticals Ltd EPS
Venmax Drugs & Pharmaceuticals Ltd
NSE: VENMAXDRUGS
EPS
Key Highlights
- The Earning per Share of Venmax Drugs & Pharmaceuticals Ltd is ₹ 0.19 as of 30 Oct 26 The earning per share of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0.02 to ₹ 0.1 over 9 quarters. This represents a CAGR of 104.48% .
Historical Earning per Share of Venmax Drugs & Pharmaceuticals Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Venmax Drugs & Pharmaceuticals Ltd
Company Fundamentals for Venmax Drugs & Pharmaceuticals Ltd
Market Cap
19 Cr
EPS
0.2
P/E Ratio (TTM)
70.5
P/B Ratio (TTM)
0.9
Day’s High
14.3
Day’s Low
12.51
DTE
0.0
ROE
1.9
52 Week High
31.49
52 Week Low
12.51
ROCE
2.0
Market Price of Venmax Drugs & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 30 Oct 2026 | 13.39 |
| 29 Oct 2026 | 12.97 |
| 28 Oct 2026 | 13.06 |
| 27 Oct 2026 | 14 |
| 26 Oct 2026 | 13.87 |
| 23 Oct 2026 | 14.48 |
| 22 Oct 2026 | 14.99 |
| 21 Oct 2026 | 14.3 |
| 19 Oct 2026 | 14.43 |
| 16 Oct 2026 | 14.5 |
SWOT Analysis Of Venmax Drugs & Pharmaceuticals Ltd
BlinkX Score for Venmax Drugs & Pharmaceuticals Ltd
Asset Value vs Market Value of Venmax Drugs & Pharmaceuticals Ltd
Market Value
₹ 19
Asset Value
Value addition
0.2 X
₹ 16
* All values are in ₹ crores
Competitive Comparison of EPS
| Company | Market Cap | EPS |
|---|
Venmax Drugs & Pharmaceuticals Ltd | 19.39 | 0.19 |
Sun Pharmaceutical Industries Ltd | 422991 | 51.3 |
Divis Laboratories Ltd | 256310 | 112.23 |
Torrent Pharmaceuticals Ltd | 173604 | 57.08 |
Laurus Labs Ltd | 121300 | 24.8 |
Zydus Lifesciences Ltd | 118304 | 48.95 |
| Company | |
|---|---|
| Venmax Drugs & Pharmaceuticals Ltd | 19.39 |
| Sun Pharmaceutical Industries Ltd | 422991 |
| Divis Laboratories Ltd | 256310 |
| Torrent Pharmaceuticals Ltd | 173604 |
| Laurus Labs Ltd | 121300 |
| Zydus Lifesciences Ltd | 118304 |
Historical Market Cap of Venmax Drugs & Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Venmax Drugs & Pharmaceuticals Ltd
Historical Revenue of Venmax Drugs & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Venmax Drugs & Pharmaceuticals Ltd
Historical EBITDA of Venmax Drugs & Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Venmax Drugs & Pharmaceuticals Ltd
Historical Net Profit of Venmax Drugs & Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Venmax Drugs & Pharmaceuticals Ltd
Dividend Payout Over Time
Venmax Drugs & Pharmaceuticals Ltd News Hub
Venmax Drugs & Pharmaceuticals to conduct board meeting
Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 Au
Read more
16 Aug 24
Venmax Drugs & Pharmaceuticals standalone net profit declines 50.00% in the June 2024 quarter
Net profit of Venmax Drugs & Pharmaceuticals declined 50.00% to Rs 0.01 crore in the quarter ended J
Read more
13 Aug 24
Venmax Drugs & Pharmaceuticals to hold board meeting
Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 Au
Read more
03 Aug 24
Venmax Drugs & Pharmaceuticals to hold AGM
Venmax Drugs & Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company w
Read more
27 Aug 24
